Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00768573
Previous Study | Return to List | Next Study

Taste Test of a New Formulation of Sildenafil (Revatio)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00768573
Recruitment Status : Completed
First Posted : October 8, 2008
Last Update Posted : April 28, 2015
Sponsor:
Information provided by (Responsible Party):
Pfizer

Tracking Information
First Submitted Date September 4, 2008
First Posted Date October 8, 2008
Last Update Posted Date April 28, 2015
Study Start Date January 2008
Actual Primary Completion Date January 2008   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: October 7, 2008)
palatability (aroma, flavour texture and mouth feel) [ Time Frame: Duration of study. ]
Original Primary Outcome Measures Same as current
Change History Complete list of historical versions of study NCT00768573 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Taste Test of a New Formulation of Sildenafil (Revatio)
Official Title A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®
Brief Summary taste of formulation
Detailed Description taste test None
Study Type Observational
Study Design Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population Healthy volunteers
Condition None Volunteer
Intervention Drug: sildenafil
Oral suspension of sildenafil.
Study Groups/Cohorts 1. Taste test
Not Specified
Intervention: Drug: sildenafil
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: May 30, 2011)
4
Original Actual Enrollment
 (submitted: October 7, 2008)
8
Actual Study Completion Date January 2008
Actual Primary Completion Date January 2008   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • History of hypersensitivity to test compounds or excipients.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 75 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00768573
Other Study ID Numbers A1481257
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Pfizer
Study Sponsor Pfizer
Collaborators Not Provided
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer
PRS Account Pfizer
Verification Date April 2015